Home
|
Inbox
|
Search
|
Speaker
Ariel Teper
MD
Sanofi
Session(s)
- A Randomized, Controlled Phase 3 Study, LIBERTY ASTHMA QUEST, Evaluating the Efficacy and ...
Sunday, May 20 2:15 PM - 4:15 PM - Dupilumab in Patients with Corticosteroid-Dependent Severe Asthma: Efficacy and Safety Res...
Monday, May 21 10:15 AM - 10:30 AM - Dupilumab Produces Rapid and Sustained Improvements in Asthma-Related Symptoms in Patients...
Tuesday, May 22 2:15 PM - 4:15 PM - Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Modera...
Tuesday, May 22 2:15 PM - 4:15 PM - Dupilumab Treatment Produces Rapid and Sustained Improvements in FEV1 in Patients with Unc...
Wednesday, May 23 9:30 AM - 9:45 AM
|
Home
|
Inbox
|
Search
|